Van Berkom & Associates Inc. raised its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 1.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,275,394 shares of the health services provider's stock after acquiring an additional 18,976 shares during the period. Maximus makes up 2.8% of Van Berkom & Associates Inc.'s portfolio, making the stock its 10th biggest position. Van Berkom & Associates Inc. owned about 2.25% of Maximus worth $86,969,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in MMS. Neo Ivy Capital Management purchased a new stake in shares of Maximus in the first quarter worth about $432,000. Cetera Investment Advisers lifted its stake in shares of Maximus by 5.8% in the first quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock worth $308,000 after acquiring an additional 247 shares in the last quarter. Advisors Preferred LLC acquired a new position in shares of Maximus in the first quarter worth about $3,958,000. Legato Capital Management LLC lifted its stake in shares of Maximus by 26.3% in the first quarter. Legato Capital Management LLC now owns 40,570 shares of the health services provider's stock worth $2,766,000 after acquiring an additional 8,436 shares in the last quarter. Finally, KLP Kapitalforvaltning AS lifted its stake in shares of Maximus by 4.9% in the first quarter. KLP Kapitalforvaltning AS now owns 25,600 shares of the health services provider's stock worth $1,746,000 after acquiring an additional 1,200 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.
Insider Transactions at Maximus
In related news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares of the company's stock, valued at $1,028,157.90. This represents a 35.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.60% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Read Our Latest Report on Maximus
Maximus Stock Up 0.7%
NYSE MMS traded up $0.48 on Wednesday, hitting $72.24. 80,901 shares of the stock traded hands, compared to its average volume of 552,039. The stock has a 50-day moving average of $71.41 and a 200 day moving average of $70.59. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a market capitalization of $4.07 billion, a P/E ratio of 14.36 and a beta of 0.61. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.87.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The business's quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.57 EPS. As a group, analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.66%. The ex-dividend date is Friday, August 15th. Maximus's dividend payout ratio (DPR) is 23.86%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.